Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at pemetrexed for advanced non small cell lung cancer (PARAMOUNT)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC)

Status:

Results

Phase:

Phase 3

Details

This trial looked at having the chemotherapy drug pemetrexed after for advanced non small cell lung cancer (NSCLC). The people taking part had types of NSCLC that are described as non squamous such as adenocarcinoma.

Recruitment start: 15 January 2009

Recruitment end: 31 March 2010

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Mayukh Das

Supported by

Eli Lilly and Company Limited

Last reviewed: 07 Jan 2014

CRUK internal database number: 1398

Help and support